recent post

Dozee Shravan to remotely monitor patients

October 8, 2024
recent post

Gleneagles Hospitals, Parel, Mumbai ropes in Dr Bipin Chevale as CEO

recent post

WHO adds an HPV vaccine for single-dose use

recent post

Global Digital Health Summit 2024 launches patient centricity index

recent post

Maxivision Super Speciality Eye Hospitals unveils advanced tech in Refractive Surgery – SMILE 500 in Vijayawada

imt Logo cross btn

Fortis, SRL Diagnostics Group contribute Rs 6 Cr to Sudha Gopalakrishnan Brain Centre

Fortis, SRL Diagnostics Group contribute Rs 6 Cr to Sudha Gopalakrishnan Brain Centre

To promote research and innovation in the country The Fortis and SRL Group of Companies contributed a sum of nearly Rs 6 crore in FY‘23 to the Sudha Gopalakrishnan Brain Centre at IIT, Madras, as a part of their Corporate Social Responsibility (CSR) mandate. The Brain Centre, launched in March 2022 at IIT-M focuses on mapping the human brain at cellular and connectivity levels and developing innovative technological solutions that will provide extraordinary and significant insights into the brain's neural networks and take the country to the world’s centre stage. Fortis and SRL Group aspire to advance healthcare technology through its social development initiatives to improve community health outcomes while focusing on the sustainable development of society. Contribution to the Brain Centre is a potent way of fostering and promoting research and development (& innovation) to benefit society's current and future generations. “As a donor to the Sudha Gopalakrishnan Brain Centre, we are delighted to support their ground-breaking brain mapping project for the advancement of modern medicine. This pioneering research perfectly aligns with our commitment to promoting and funding innovation in medical sciences. As a healthcare services provider, our aim in this collaboration is to foster revolutionary solutions that will pave the way for the future of healthcare innovation for decades to come," said Dr Ashutosh Raghuvanshi, MD and CEO, Fortis Healthcare. “At SRL, we remain steadfast in our objective to enhance and uphold human health and well-being, and we believe that supporting pioneering research institutions like the Sudha Gopalakrishnan Brain Centre is key to achieving this goal. We take immense pride in being a part of the progress of the global healthcare industry by contributing to the revolutionary research that will pave the way for the future of healthcare,” added Anand K, CEO, SRL Diagnostics. Kris Gopalakrishnan, Co-founder, Infosys and Distinguished Alumnus, IIT-M, said, “The trust and confidence demonstrated by the Fortis Group of Companies towards the Brain Centre through their generous contribution is invaluable. It displays the exemplary commitment of the Company to support cutting-edge research in the country. I hope that this contribution will inspire other organizations to come forward to support such research efforts at IIT Madras.” Prof Mohanasankar Sivaprakasam who heads the IIT Madras Brain Centre said, “This support by Fortis Group of Companies is timely and essential towards achieving the vision of the Brain Centre of becoming a globally leading brain research Centre that produces highly sought after human brain data and technology tools.”